FDA Approves New Treatment for Moderate-to-Severe Plaque Psoriasis

The FDA has approved bimekizumab for the treatment of adults with moderate-to-severe plaque psoriasis. Learn about this new treatment option.

ReachMD Healthcare Image
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free